Antiphospholipid Antibodies in Malignancy Are These Pathogenic or Epiphenomena?

被引:5
|
作者
Mahaum, Nayab [1 ]
Prete, Pamela E. [1 ,2 ]
机构
[1] Univ Calif Irvine, Dept Med, Div Rheumatol, Irvine, CA 92717 USA
[2] Vet Adm, Rheumatol Sect, Long Beach, CA USA
关键词
antiphospholipid antibodies; antiphospholipid syndrome; malignancy; cancer; CLINICAL-SIGNIFICANCE; PREVALENCE; LYMPHOMA;
D O I
10.1097/RHU.0b013e31823b0ca5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by arterial and venous thrombotic events associated with antiphospholipid antibodies. Antiphospholipid syndrome is commonly seen with collagen vascular diseases; however, other entities that can cause APS include chronic viral infections, certain medications, and malignancies. We present an interesting patient with an atypical presentation and course of presumed APS, which lead us to perform an exhaustive search for a secondary cause. The patient was ultimately found to have splenic marginal zone lymphoma. Analysis of the current data in the literature is presented for APS, antiphospholipid antibodies, and malignancy. Based on the literature findings and our experience, we recommend a thorough and repeated evaluation for an underlying malignancy in patients who have an atypical presentation and features of APS.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 50 条
  • [1] Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms
    Pierangeli, Silvia S.
    Chen, Pojen P.
    Raschi, Elena
    Scurati, Silvia
    Grossi, Claudia
    Borghi, Maria Orietta
    Palomo, Ivan
    Harris, E. Nigel
    Meroni, Pier Luigi
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (03): : 236 - 250
  • [2] Pathogenic role of antiphospholipid antibodies
    Salmon, J. E.
    de Groot, P. G.
    [J]. LUPUS, 2008, 17 (05) : 405 - 411
  • [3] Pathogenic role of antiphospholipid antibodies: an update
    Fujieda, Y.
    Amengual, O.
    Atsumi, T.
    [J]. LUPUS, 2018, 27 (13) : 2012 - 2013
  • [4] Antiphospholipid antibodies: a mosaic of pathogenic effects?
    Pierangeli, SS
    [J]. BLOOD, 2004, 104 (09) : 2619 - 2620
  • [5] Antiphospholipid antibodies and the antiphospholipid syndrome:: an update on treatment and pathogenic mechanisms
    Pierangeli, Silvia S.
    Chen, Pojen P.
    Gonzalez, Emilio B.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2006, 13 (05) : 366 - 375
  • [6] Pregnancies complicated with antiphospholipid syndrome: The pathogenic mechanism of antiphospholipid antibodies - A review of the literature
    Di Simone, Nicoletta
    Luigi, Meroni Pier
    Marco, D'Asta
    Fiorella, Di Nicuolo
    Silvia, D'Ippolito
    Clara, D'Alessio Maria
    Alessandro, Caruso
    [J]. AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, 2007, 1108 : 505 - 514
  • [7] PATHOGENIC POTENTIAL OF ANTIPHOSPHOLIPID ANTIBODIES - BINDING TO HUMAN PLATELETS
    CHESTERMAN, CN
    CHONG, BH
    SHI, W
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 848 - 848
  • [8] ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOTIC PREDISPOSITION - UNDERLYING PATHOGENIC MECHANISMS
    SANTORO, SA
    [J]. BLOOD, 1994, 83 (09) : 2389 - 2391
  • [9] E-Selectin mediates pathogenic effects of antiphospholipid antibodies
    Espinola, RG
    Liu, X
    Colden-Stanfield, M
    Hall, J
    Harris, EN
    Pierangeli, SS
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) : 843 - 848
  • [10] Pathogenic effects of antiphospholipid antibodies are mediated by E-selectin.
    Pierangeli, SS
    Espinola, RG
    Liu, XW
    Colden-Stanfield, M
    Harris, EN
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S190 - S190